Quotes for Hunter Capital RTO 1 AB
Right Now
- +/-
- %
- 0,00%
- Latest
- High
- Low
- Volume
- 0
- Turnover (SEK)
- 0
- Market Value (MSEK)
- 22,1
- Time (Latest trade)
Board
CEO
- Jacob Eriksson
Chairperson of the Board
- Oliver Aleksov
Board
- Jacob Eriksson
- Per Karlsson
Hunter Capital RTO 1 AB
Hunter Capital RTO1 is a company shell to be listed, which will then be used to list another company via a reverse acquisition. The company seeks to acquire one or more companies and associated assets in the financial markets, primarily through mergers, IPOs, acquisitions, share purchases and major reorganizations. Hunter Capital is behind the company.
News
- Hunter Capital RTO 1 publicerar delårsrapport januari – mars 2026
- Kallelse till årsstämma i Hunter Capital RTO 1 AB (publ)
- Hunter Capital RTO 1 signs Letter of Intent for reverse takeover of Nordic Phase 2 biotech company at an implied valuation of SEK 365–405 million
- Hunter Capital RTO 1 ingår avsiktsförklaring om omvänt förvärv av nordiskt bioteknikbolag i fas 2 till en implicerad värdering om 365–405 MSEK
- Hunter Capital RTO 1 AB (publ) publicerar årsredovisning för 2025
News agencies
- Finwire: Hunter Capital RTO1 reports a smaller loss
- Finwire: Hunter Capital RTO1 enters into a letter of intent for reverse acquisition of Resother Pharma
- Finwire: Hunter Capital RTO1 clarifies insider transaction (update)
- Finwire: Hunter Capital RTO1"s chairman Oliver Aleksov makes a minor share sale
Insider trading
*Powered by Modular Finance
Key Numbers
*Compiled data from Millistream
Upcoming reports
-
2026-06-26 Annual General Meeting 2025
-
2026-08-31 Interim Report 2026-Q2
-
2026-11-27 Interim Report 2026-Q3